Paper41594138
Lipopeptide Engineering: From Natural Origins to Rational Design Against Antimicrobial Resistance.
Xie SY and 4 others. Antibiotics (Basel), 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Lipopeptide Engineering: From Natural Origins to Rational Design Against Antimicrobial Resistance. Papers, record 41594138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41594138
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipopeptide Engineering: From Natural Origins to Rational Design Against Antimicrobial Resistance.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References287
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40804173 | Target sequence-conditioned design of peptide binders using masked language modeling. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/40804173 | PubMed |
| 2 | 28074057 | Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections. | J Antibiot (Tokyo) | 2017 | https://conductscience.org/library/papers/28074057 | PubMed |
| 3 | 34987225 | A naturally inspired antibiotic to target multidrug-resistant pathogens. | Nature | 2022 | https://conductscience.org/library/papers/34987225 | PubMed |
| 4 | 29412662 | Synthesis and Bioactivity Investigation of the Individual Components of Cyclic Lipopeptide Antibiotics. | J Med Chem | 2018 | https://conductscience.org/library/papers/29412662 | PubMed |
| 5 | 38270541 | Multi_CycGT: A Deep Learning-Based Multimodal Model for Predicting the Membrane Permeability of Cyclic Peptides. | J Med Chem | 2024 | https://conductscience.org/library/papers/38270541 | PubMed |
| 6 | 31630240 | C16-Fengycin A affect the growth of Candida albicans by destroying its cell wall and accumulating reactive oxygen species. | Appl Microbiol Biotechnol | 2019 | https://conductscience.org/library/papers/31630240 | PubMed |
| 7 | 30070831 | P450-Catalyzed Tailoring Steps in Leinamycin Biosynthesis Featuring Regio- and Stereoselective Hydroxylations and Substrate Promiscuities. | Biochemistry | 2018 | https://conductscience.org/library/papers/30070831 | PubMed |
| 8 | 29566483 | Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules. | ACS Infect Dis | 2018 | https://conductscience.org/library/papers/29566483 | PubMed |
| 9 | 16109938 | The heat shock genes dnaK, dnaJ, and grpE are involved in regulation of putisolvin biosynthesis in Pseudomonas putida PCL1445. | J Bacteriol | 2005 | https://conductscience.org/library/papers/16109938 | PubMed |
| 10 | 24702006 | Bacterial multidrug efflux transporters. | Annu Rev Biophys | 2014 | https://conductscience.org/library/papers/24702006 | PubMed |
| 11 | 39103572 | Aspergillus cvjetkovicii protects against phytopathogens through interspecies chemical signalling in the phyllosphere. | Nat Microbiol | 2024 | https://conductscience.org/library/papers/39103572 | PubMed |
| 12 | 26991102 | Chemical Probes Allow Structural Insight into the Condensation Reaction of Nonribosomal Peptide Synthetases. | Cell Chem Biol | 2016 | https://conductscience.org/library/papers/26991102 | PubMed |
| 13 | 29485690 | New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin B and colistin. | Med Res Rev | 2018 | https://conductscience.org/library/papers/29485690 | PubMed |
| 14 | 21464247 | Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21464247 | PubMed |
| 15 | 28128096 | Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate. | Int J Antimicrob Agents | 2016 | https://conductscience.org/library/papers/28128096 | PubMed |
| 16 | 36399613 | Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids. | J Med Chem | 2022 | https://conductscience.org/library/papers/36399613 | PubMed |
| 17 | 26922212 | Anaphylaxis to polymyxin B-trimethoprim eye drops. | Ann Allergy Asthma Immunol | 2016 | https://conductscience.org/library/papers/26922212 | PubMed |
| 18 | 38843834 | Discovery of antimicrobial peptides in the global microbiome with machine learning. | Cell | 2024 | https://conductscience.org/library/papers/38843834 | PubMed |
| 19 | 28893780 | Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28893780 | PubMed |
| 20 | 24531506 | Salmonellae PhoPQ regulation of the outer membrane to resist innate immunity. | Curr Opin Microbiol | 2014 | https://conductscience.org/library/papers/24531506 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41594138
GET https://conductscience.org/api/papers/v1/41594138/references?page=2